Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
23. July 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 97878
Articles 1 - 20 / 1957559
Comparative Efficacy of Dynamic and Contact Cooling With the Fifth-generation Pulsed Dye Laser for Breast Surgical Scars in Cancer Survivors.
Plast Reconstr Surg Glob Open
Waibel J, Portocarrero CV, Quiñonez RL, Sedaghat ES, Hu JK, Burnet A.
PMID: 42488918 [PubMed]
Evaluating an RNA-based test for proliferation assessment and recurrence prediction in early HR+/HER2- breast cancer.
Pathol Oncol Res
Vetter M, Chiru ED, Gasior A, Gorniak J, Rollinson S, Gough L, Harrison M, Sonderegger-Stalder M, Matter M, Muenst S, Kurzeder C.
PMID: 42488884 [PubMed - indexed for MEDLINE]
Determinants of Cervical Cancer Screening Uptake Among Antenatal Women in a Semi-Urban Hospital in Ebonyi State, Nigeria.
Niger Med J
Onyema CM, Nweke AN, Oliobi CW, Chimezie-Chilaka C, Ekpe CN, Uche-Nwidagu NB.
PMID: 42488872 [PubMed]
A Simplified Nomogram for Primary Population-Based Screening of Esophageal Cancer: An Internally Validated Shandong Cohort Study Addressing Data Imbalance.
Risk Manag Healthc Policy
Hou J, He X, Gao F, Ren T, Ren L, Wang X.
PMID: 42488795 [PubMed]
An Overview of Emerging Trends in Targeted Therapy of Triple-Negative Breast Cancer.
Int J Breast Cancer
Kumar A, Subramanian S.
PMID: 42488779 [PubMed]
Outcomes of cervical carcinoma patients treated with chemoradiation and single-application two-fractions schedule of high-dose-rate brachytherapy: A retrospective review (SATF study).
J Contemp Brachytherapy
Shinghal A, Chakravarty A, Singla T, Kapoor AR, Datta A, Giridhar P, Pujari L, Pradhan S.
PMID: 42488738 [PubMed]
Gastrointestinal conventional carcinoma with neuroendocrine differentiation: From pathological phenomenon to clinical importance (Review).
Oncol Lett
Zhou C, Tong S, Zhou D, Pan Y, Xu J, Ling S, Wu W, Feng T.
PMID: 42488712 [PubMed]
Cell-cycle reactivation and hepatocyte identity loss in hepatocellular carcinoma: Transcriptomic hallmarks and validation strategies (Review).
Oncol Lett
Hou J, Zhu B, Liang L.
PMID: 42488711 [PubMed]
Safety and Efficacy of Aumolertinib as First-Line Treatment in EGFR-Mutant Lung Adenosquamous Carcinoma: A Multicenter, Single-Arm, Prospective Phase II Study (ARISE Study).
MedComm (2020)
Zhang L, Huang L, Huang D, Liu Z, Yu Y, Miao K, Miao Q, Zheng X, Xu Y, Chu Q, Lin G.
PMID: 42488708 [PubMed]
Tumor Plasticity and Microenvironmental Crosstalk as Drivers of Metastasis and Therapy Resistance.
MedComm (2020)
Dagar G, Dagar M, Gupta A, Surendranath A, Das SK, Rehmani MU, Tanwar M, Mirza S, Macha MA, Akil ASA, Uddin S, Singh M, Bhat AA.
PMID: 42488707 [PubMed]
Early-Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection.
MedComm (2020)
Xiong X, Zhu W, Huang W, Zhang S, Deng Q, Yang J, Xu H, Wei Q, Yang L.
PMID: 42488705 [PubMed]
Efficacy and safety of combining radiotherapy with first-line chemotherapy and immunotherapy for local advanced/metastatic urothelial cancer: a propensity score matching analysis.
Front Immunol
Qin J, Zhou H, Li X, Yin H, Deng H, Luo Y, Chen Y, Yin Y, Zhou R, Zhan N, Zheng Y, Zhang T, He W.
PMID: 42488678 [PubMed - indexed for MEDLINE]
Cholesterol metabolic rewiring shapes immune remodeling across hepatocarcinogenesis.
Front Immunol
Ma W, Yan F, Cheng Y, Zhang G, Mu Y, Zhang Z, Liang X, Gan J, Yang W, Zhu W, Cheng Y.
PMID: 42488674 [PubMed - indexed for MEDLINE]
Mitochondrial reprogramming in cervical cancer: crosstalk with tumor immunity, HPV oncogenic signaling, and therapeutic resistance.
Front Immunol
Pan L, Zhang P, Zhang D, Wang G.
PMID: 42488672 [PubMed - indexed for MEDLINE]
Prognostic significance of continuing immunotherapy beyond progression in unresectable lung adenocarcinoma.
Front Immunol
Hu F, Zheng L, Xu H, Pan F, Nie W, Zhong R, Lou Y, Han B, Zheng X, Zhong H, Zhang X.
PMID: 42488667 [PubMed - indexed for MEDLINE]
Vaccination-enabled immune readiness for checkpoint blockade.
Front Immunol
Bautista J, López-Cortés A.
PMID: 42488666 [PubMed - indexed for MEDLINE]
CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors.
Front Immunol
Liu X, Tong F, Zhang J, Gradishar W, Liu H, Wang R.
PMID: 42488656 [PubMed - indexed for MEDLINE]
CGRP: the immune system's double agent - context-dependent roles in inflammation, resolution and cancer.
Front Immunol
Assas MB.
PMID: 42488654 [PubMed - indexed for MEDLINE]
Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization.
Front Immunol
Song J, He Z, Han C, Hou X.
PMID: 42488653 [PubMed - indexed for MEDLINE]
Enhancing CAR-NK persistence to unlock its full therapeutic potentials.
Front Immunol
Amarasinghe O, Ma H, Tremblay CS, Kung SKP.
PMID: 42488645 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 1957559
Page 1 of 97878
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy